Are market darlings Bellamy's Australia Ltd and 1-Page Ltd higher risk investments?

Have you considered the risks before investing in Bellamy's Australia Ltd (ASX:BAL), Blackmores Limited (ASX:BKL) or 1-Page Ltd (ASX:1PG)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At any one time within the investing community, there are always the market darlings, unable to put a foot wrong, and the ugly ducklings, often discarded and unloved.

Contrast the current optimism toward health food providers with Chinese exposure, including Bellamy's Australia Ltd (ASX: BAL) and Blackmores Limited (ASX: BKL), to the doom and gloom of the beaten-down resources sector.

There are strong fundamental economic reasons for both of these views. However, investors can hurt their returns (1) when buying overpriced market darlings and (2) by avoiding currently unloved companies, sectors and industries in which a few hidden gems could be hiding.

This article looks at a few of the recent market darlings.

Chinese exposure

Bellamy's FY15 net profit after tax (NPAT) was $9.1 million and its current market cap is $930 million. Its trailing price to earnings (P/E) ratio is around 100.

If NPAT doubles in FY16 and again in FY17 to $36m, the company would have a price to earning (P/E) multiple of 25 which could be considered a crude approximation of fair value. This implies that around 2 years of 100% NPAT growth is factored into the current share price.

While it is possible that Bellamy's could achieve this growth, it increases the risk of an investment in the shares at current prices.

Blackmores reported FY15 NPAT was $46.6 million and has a current market cap of $2.9 billion. Its trailing PE ratio is 62.

The average analyst on Yahoo! Finance estimates that Blackmores will grow NPAT by 80% in FY16 and then again by 25% in FY17 to $100 million. At this point, the PE ratio would be 29 and again indicates that around 2 years of substantial earnings growth is factored into the price.

Technology startups

1-Page Ltd (ASX: 1PG) is trying to revolutionise the way in which companies source and hire new employees. This potential has clearly excited investors, pushing the stock up more than 1000% in the past year.

The business reported revenue of just $159,000 in FY15 and a loss after tax of $8.4 million, yet has a market capitalisation of $460 million.

Compare this to established company Seek Limited (ASX: SEK) which reported FY15 revenue and underlying NPAT of $859 million and $196 million, respectively, and has a market cap of $4.8 billion – only 10x that of 1-Page.

1-Page generates little revenue, burns a lot of cash and it is anyone's guess as to when it could become profitable – if it ever does.

Reffind Ltd (ASX: RFN) is another company aiming to secure a piece of the jobs market. Similar to 1-Page, Reffind produced little revenue during FY15 ($21,000) while burning through cash developing its products.

Again, investors buying Reffind today are speculating that its products will gain acceptance in the market and that the business will eventually become profitable.

Foolish Takeaway

Be careful and appreciate the risks involved with market darlings sporting sky-high share prices with expected massive future growth. Low-risk investors who value capital preservation might be advised to look elsewhere.

If you have a higher risk tolerance, these types of investments can provide huge returns – but conversely could also see a total wipeout of your capital. It also pays to remember that any miss of investor's lofty expectations will likely see the share prices hammered.

A suggestion for these investors is to buy incrementally into the company at three different times over the next 1 to 2 years as the business proves itself. You could miss out on some early returns, but you will also likely avoid some significant losses.

Motley Fool contributor Mitch Sonogan owns shares of SEEK Limited. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »